Attendees at the GF Securities Life Science Investment Conference 2017 in Guangzhou will include over 50 major, listed companies in China, such as By-Health, Fosun Pharma, Hisun, Livzon, Shanghai Pharma, SL Pharm, Tasly, Walvax and Wondfo. Meet with senior executives from these and other companies that are seeking investment, in-licensing, distribution, partnering and acquisition opportunities to expand their products and global market access.